Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background</h3><p>Mutations in the <em>RAG</em> genes cause severe immunodeficiency, with a spectrum of phenotypes ranging from severe combined immunodeficiency to immune dysregulation. Hematopoietic stem cell transplantation is the only curative option, but a high risk of graft failure and poor immune reconstitution have been observed in the absence of myeloablation.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Objectives</h3><p>To improve multi-lineage engraftment, we tested non-genotoxic conditioning with anti-CD45-Saporin (CD45-SAP).</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p><em>Rag1-KO</em> and <em>Rag1-F971L</em> mice, which represent models of SCID and of combined immune deficiency with immune dysregulation, respectively, were conditioned with CD45-SAP, CD45-SAP + 2Gy, 2Gy, 8Gy or no conditioning, and transplanted with Lineage-negative bone marrow cells from wild-type mice. Flow cytometry and immunohistochemistry were used to assess engraftment and immune reconstitution. Antibody responses to TNP-KLH were measured by ELISA, and presence of autoantibody was detected by microarray.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>Conditioning with CD45-SAP enabled high levels of multi-lineage engraftment in both <em>Rag1</em> mutant models, allowed overcoming of B and T cell differentiation blocks and of thymic epithelial cell defects and induced robust cellular and humoral immunity in the periphery.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p>Conditioning with CD45-SAP allows multilineage engraftment and robust immune reconstitution in mice with either null or hypomorphic <em>Rag</em> mutations, while preserving thymic epithelial cell homeostasis.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Clinical implications</h3><p>Conditioning with anti-CD45 antibody-drug conjugates may represent a novel and safe conditioning regimen for patients with <em>RAG</em> deficiency and other inborn errors of immunity.</p>

Hypomorphic mutation in the RAG2 gene affects dendritic cell distribution and migration

Cutaneous barrier leakage and gut inflammation drive skin disease in Omenn syndrome

The R229Q mutation of Rag2 does not characterize severe immunodeficiency in mice

Whole-exome sequencing identified a homozygous novel RAG1 mutation in a child with omenn syndrome

Clinical, Immunologic, and Genetic Characteristics of RAG Mutations in 15 Chinese Patients with SCID and Omenn Syndrome.

RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement

A novel RAG1 mutation in a compound heterozygous status in a child with Omenn syndrome

RAG1 splicing mutation causes enhanced B cell differentiation and autoantibody production

RAG deficiencies: Recent advances in disease pathogenesis and novel therapeutic approaches

Emerging therapy options may help patients with RAG deficiency, especially those with severe immune dysregulation

RAG suppresses group 2 innate lymphoid cells

Partial T cell defects and expanded CD56bright NK cells in an SCID patient carrying hypomorphic mutation in the IL2RG gene

Recombination activity of human recombination-activating gene 2 (RAG2) mutations and correlation with clinical phenotype

Deficiency in IL-17-committed Vγ4+ Γδ T Cells in a Spontaneous Sox13-mutant CD45.1+ Congenic Mouse Substrain Provides Protection from Dermatitis

Restricted heterogeneity of T lymphocytes in combined immunodeficiency with hypereosinophilia (Omenn's syndrome)

Late Onset Hypomorphic RAG2 Deficiency Presentation with Fatal Vaccine-Strain VZV Infection

iPSC-Based Modeling of RAG2 Severe Combined Immunodeficiency Reveals Multiple T Cell Developmental Arrests

Loss of tolerance and autoimmunity affecting multiple organs in STAT5A/5B-deficient mice

RAG-2 deficiency results in fewer phosphorylated histone H2AX foci, but increased retinal ganglion cell death and altered axonal growth

Efficacy and safety of anti-CD45–saporin as conditioning agent for RAG deficiency

Biological Characteristics of Severe Combined Immunodeficient Mice Produced by CRISPR/Cas9-Mediated Rag2 and IL2rg Mutation